Pretreatment CRP serum concentrations in patients with TETs with paraneoplastic MG (0.91 ± 0.56 mg/dL) were not significantly different compared to those patients without MG (1.08 ± 0.25md/dL; p = 0.753; Table 1). The gene discussed is CRP; the disease is myasthenia gravis.